Na/K-ATPase amplification of oxidant stress; a universal but unrecognized clinical target?

The Na/K-ATPase has a signaling function which appears to be separate from its ion pumping function. This signaling function refers to the transduction of conformational changes in the Na/K-ATPase alpha1 subunit into activating Src’s tyrosine kinase activity, triggering a cascade which generates rea...

Full description

Bibliographic Details
Main Authors: Zijian Xie, Joseph I. Shapiro
Format: Article
Language:English
Published: Marshall University 2016-04-01
Series:Marshall Journal of Medicine
Subjects:
Online Access:https://mds.marshall.edu/cgi/viewcontent.cgi?article=1042&context=mjm
id doaj-b124caf0d3024a40826e0a7ecde2e350
record_format Article
spelling doaj-b124caf0d3024a40826e0a7ecde2e3502020-11-25T02:40:48ZengMarshall UniversityMarshall Journal of Medicine 2379-95362016-04-0122814http://dx.doi.org/10.18590/mjm.2016.vol2.iss2.4Na/K-ATPase amplification of oxidant stress; a universal but unrecognized clinical target?Zijian Xie0Joseph I. Shapiro1Marshall UniversityMarshall UniversityThe Na/K-ATPase has a signaling function which appears to be separate from its ion pumping function. This signaling function refers to the transduction of conformational changes in the Na/K-ATPase alpha1 subunit into activating Src’s tyrosine kinase activity, triggering a cascade which generates reactive oxygen species (ROS), modulates other signaling pathways, and causes many physiological and pathophysiological effects. We have recently observed that ROS themselves as well as cardiotonic steroids can actually initiate the signal by directly inducing conformational changes in alpha1. It therefore appears that the Na/K-ATPase signal cascade can serve as a feed forward amplification for ROS with circulating cardiotonic steroids setting the gain. Work in both cellular and animal models of disease suggest that this amplification process is activated in conditions characterized by oxidant stress ranging from cancer to obesity/metabolic syndrome and may serve as a potential clinical target for interventions.https://mds.marshall.edu/cgi/viewcontent.cgi?article=1042&context=mjmNa/K-ATPaseoxidant stresshypertensionfibrosisrenal failureobesity
collection DOAJ
language English
format Article
sources DOAJ
author Zijian Xie
Joseph I. Shapiro
spellingShingle Zijian Xie
Joseph I. Shapiro
Na/K-ATPase amplification of oxidant stress; a universal but unrecognized clinical target?
Marshall Journal of Medicine
Na/K-ATPase
oxidant stress
hypertension
fibrosis
renal failure
obesity
author_facet Zijian Xie
Joseph I. Shapiro
author_sort Zijian Xie
title Na/K-ATPase amplification of oxidant stress; a universal but unrecognized clinical target?
title_short Na/K-ATPase amplification of oxidant stress; a universal but unrecognized clinical target?
title_full Na/K-ATPase amplification of oxidant stress; a universal but unrecognized clinical target?
title_fullStr Na/K-ATPase amplification of oxidant stress; a universal but unrecognized clinical target?
title_full_unstemmed Na/K-ATPase amplification of oxidant stress; a universal but unrecognized clinical target?
title_sort na/k-atpase amplification of oxidant stress; a universal but unrecognized clinical target?
publisher Marshall University
series Marshall Journal of Medicine
issn 2379-9536
publishDate 2016-04-01
description The Na/K-ATPase has a signaling function which appears to be separate from its ion pumping function. This signaling function refers to the transduction of conformational changes in the Na/K-ATPase alpha1 subunit into activating Src’s tyrosine kinase activity, triggering a cascade which generates reactive oxygen species (ROS), modulates other signaling pathways, and causes many physiological and pathophysiological effects. We have recently observed that ROS themselves as well as cardiotonic steroids can actually initiate the signal by directly inducing conformational changes in alpha1. It therefore appears that the Na/K-ATPase signal cascade can serve as a feed forward amplification for ROS with circulating cardiotonic steroids setting the gain. Work in both cellular and animal models of disease suggest that this amplification process is activated in conditions characterized by oxidant stress ranging from cancer to obesity/metabolic syndrome and may serve as a potential clinical target for interventions.
topic Na/K-ATPase
oxidant stress
hypertension
fibrosis
renal failure
obesity
url https://mds.marshall.edu/cgi/viewcontent.cgi?article=1042&context=mjm
work_keys_str_mv AT zijianxie nakatpaseamplificationofoxidantstressauniversalbutunrecognizedclinicaltarget
AT josephishapiro nakatpaseamplificationofoxidantstressauniversalbutunrecognizedclinicaltarget
_version_ 1724779655620198400